Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode (original) (raw)
Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia
Steffen Moritz, D. Naber, Prof. Dr. Martin Lambert
Acta Psychiatrica Scandinavica, 2005
View PDFchevron_right
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response
Isabell Heuser
Psychiatry Research, 2008
View PDFchevron_right
Psychotic symptoms in patients with medical disorders
Rajnish Mago
Current Psychiatry Reports, 2004
View PDFchevron_right
Effect of Antipsychotic Withdrawal on Negative Symptoms in Schizophrenia
Stephan Arndt
Neuropsychopharmacology, 1994
View PDFchevron_right
Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians
Glenn Phillips
Patient Preference and Adherence, 2011
View PDFchevron_right
Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia
Ronald Marcus
The International Journal of Neuropsychopharmacology, 2003
View PDFchevron_right
Does Combined Antipsychotic Treatment Provide Better Control on Symptoms in Patients with Schizophrenia than the Monotherapy?
Volkan Sahiner
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2016
View PDFchevron_right
Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic
Dr. Hülya Ensari
Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014
View PDFchevron_right
Current State of Psychopharmacology, Psychotherapies and Other Interventions in Mental Health Problems and Disorders
José Bertolín-Guillén
Advances in Image and Video Processing, 2021
View PDFchevron_right
Common Mental Disorders: Integration of Psychotherapy as a Treatment in Addition to the Use of Psychotropic Drugs
Nayla Saadi Senna
International Journal of Sciences, 2024
View PDFchevron_right
Antipsychotic Drugs
Melissa Piasecki
Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery
View PDFchevron_right
Clozapine versus other atypical antipsychotics for schizophrenia
Claudia Asenjo-Lobos
Cochrane Database of Systematic Reviews, 2010
View PDFchevron_right
Tranquilising agitated mentally ill patients: intramuscular haloperidol plus promethazine reduces need for additional medication or medical attention compared to olanzapine
Prathap Tharyan
Evidence-based Mental Health, 2008
View PDFchevron_right
Rational Polypharmacy in Psychiatry
Sai Krishna Tikka
Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine, 2015
View PDFchevron_right
Today’s psychopharmacological treatments: results, problems, new perspectives
Selim Kiliç
Bulletin of Clinical Psychopharmacology, 2012
View PDFchevron_right
Second Generation Long-Acting Antipsychotics in the Treatment of Bipolar Disorder: A Clinical Viewpoint
Alessandro Carano
Bipolar Disorder, 2018
View PDFchevron_right
Health-Related Quality of Life in People Living with Psychotic Illness and Factors Associated with Its Variation
Vaughan Carr
Value in Health, 2018
View PDFchevron_right
Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence?
Nele Vriendt
BMC Psychiatry, 2012
View PDFchevron_right
P.2.020 Comparison of efficacy and tolerability of quetiapine and haloperidol in acute exacerbation of chronic or subchronic schizophrenia
M. Bilici
European Neuropsychopharmacology, 2003
View PDFchevron_right
2nd Schizophrenia International Research Society Conference
Renan Souza
Schizophrenia Research, 2009
View PDFchevron_right
Mental Health Patient-Reported Outcomes and Experiences Assessment in Portugal
Niek Klazinga
International Journal of Environmental Research and Public Health, 2022
View PDFchevron_right
Proposing a causal pathway for health-related quality of life in people with psychotic disorders
Vaughan Carr
Journal of Psychiatric Research, 2021
View PDFchevron_right
Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression
Judith D Weissman
Psychiatry Research, 2012
View PDFchevron_right
Effectiveness of Pharmacotherapy for Severe Personality Disorders
Theo Ingenhoven
The Journal of Clinical Psychiatry, 2009
View PDFchevron_right
The positive impact of cariprazine in schizophrenia treatment management – case report
Diana-Elena Nistor
Romanian Journal of Psychiatry & Psychotherapy, 2022
View PDFchevron_right